CHAN, Ho Man,GU, Xiang-Ju Justin,HUANG, Ying,LI, Ling,MI, Yuan,QI, Wei,SENDZIK, Martin,SUN, Yongfeng,WANG, Long,YU, Zhengtian,ZHANG, Hailong,ZHANG, Ji Yue (jeff),ZHANG, Man,ZHANG, Qiong,ZHAO, Kehao
申请号：
TN2017000204
公开号：
TN2017000204A1
申请日:
2015.12.21
申请国别(地区):
TN
年份:
2018
代理人:
摘要：
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R<；sup>；1 <；/sup>；, R<；sup>；2 <；/sup>；, R<；sup>；3 <；/sup>；, R<；sup>；4 <；/sup>；, R<；sup>；5<；/sup>；, and n are as defined herein.<；br />；
